EGFR and laryngotracheoesophageal cleft: As postoperative patients with LC treated with adjuvant thymosin were stage I-IIIA and primarily stage I, whereas the other study included LUAD patients in the analysis were stage IV, the different effects of EGFR-TKIs in combination with thymosin may be related to staging.